PBR has a higher market value than 95.8% of US stocks; more precisely, its current market capitalization is $35,415,006,424.
PBR's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1.08 -- higher than only 11.11% of US-listed equities with positive expected earnings growth.
Petrobra's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 67.03%, greater than the shareholder yield of 93.24% of stocks in our set.
Stocks that are quantitatively similar to PBR, based on their financial statements, market capitalization, and price volatility, are LVS, CP, NSC, S, and KHC.
Petroleo Brasileiro S.A.- Petrobras (PBR) Company Bio
PetroBras operates as an integrated energy company in Brazil and internationally. The Company operates in the Exploration and Production, Refining, Transportation and Marketing, Gas and Power, Biofuels, Distribution, and International segments. The company was founded in 1953 and is based in Rio de Janeiro, Brazil.
PBR Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Petrobra. To summarize, we found that Petrobra ranked in the 70th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 217.5%. As for the metrics that stood out in our discounted cash flow analysis of Petrobra, consider:
Petrobra's weighted average cost of capital (WACC) is 6%; for context, that number is higher than only 5.73% of tickers in our DCF set.
As a business, Petrobra experienced a tax rate of about 21% over the past twelve months; relative to its sector (Energy), this tax rate is higher than 78.48% of stocks generating free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Petrobra? See COP, LBRT, MTRX, NCSM, and CKH.